DIAMEDICA THERAPEUTICS INC (DMAC) Stock Income Statement
NASDAQ:DMAC - Nasdaq - CA25253X2077 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 26.68M | 21.27M | 14.00M | 13.65M | 12.70M | |||
| Research and Development | 19.06M | 13.11M | 7.84M | 8.77M | 8.31M | |||
| Selling, General, and Administrative Expenses | 7.62M | 8.16M | 6.16M | 4.88M | 4.39M | |||
| Operating Income | -26.68M | -21.27M | -14.00M | -13.65M | -12.70M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Other Income/Expense | 2.27M | 1.93M | 353.00K | 82.00K | 434.00K | |||
| Income Before Taxes | -24.41M | -19.34M | -13.65M | -13.56M | -12.27M | |||
| Income Tax | 30.00K | 43.00K | 28.00K | 28.00K | 27.00K | |||
| Net Income | -24.44M | -19.38M | -13.68M | -13.59M | -12.29M | |||
| EBITDA | -26.64M | -21.24M | -13.98M | -13.62M | -12.68M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.60 | -0.60 | -0.52 | -0.65 | -0.78 | |||
| Non GAAP EPS | -0.60 | -0.62 | -0.52 | -0.64 | -0.78 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD